Bowel cancer: the development and impact of cancer in the colon or rectum.
Sydney Towle, 26, is transitioning to hospice care after years of cholangiocarcinoma treatment. Her brother’s TikTok updates have chronicled her journey, including a recent shift away from aggressive therapy toward comfort-focused care as she continues to seek innovative options.
The FDA has approved daraxonrasib, sold as Rasonque by Revolution Medicines, for adults with previously treated or ineligible metastatic pancreatic cancer. Clinical trials have shown median survival extended to about 13.2 months versus roughly 6.7 months with chemotherapy. The drug will be available in the US with a roughly $39,800 monthly list price and expanded-access programmes have already treated thousands.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
Investors have pushed new biotech winners — from Novo Nordisk’s semaglutide pill to startups tackling baldness and targeted autoimmune drugs — while market enthusiasm has cooled for some forecasts. Novo Nordisk has released a daily weight‑loss pill used by over 1.5 million people; hair‑loss startups have sent small caps soaring; India’s low‑cost GLP‑1 generics have underperformed expectations.
A new analysis shows a rise in cancers among people under 50 across England, the US and the Netherlands, driven by obesity, diet and lifestyle factors, with bowel, kidney and uterine cancers among the fastest-growing. Experts urge research and prevention as diagnosis at younger ages becomes more common.
The Dyson airsmooth has launched as Dyson’s most affordable hair tool, aiming to deliver a salon-style blow-dry at a lower price. Independent’s Sabrina Sahota and colleagues have tested it against pricier models, reporting easy glide and smooth results, though roots may require extra drying time. In parallel, consumers praise Hershesons’ wand for curl-hold and Mdlondon’s curling wand for versatility, while Richualist’s Mint promises rapid, detangled styling via refurbished product pods.